Cargando…

Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies

Cancer is a death cause in economically developed countries that results growing also in developing countries. Improved outcome through targeted interventions faces the scarce selectivity of the therapies and the development of resistance to them that compromise the therapeutic effects. Genomic inst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davalli, Pierpaola, Marverti, Gaetano, Lauriola, Angela, D'Arca, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892224/ https://www.ncbi.nlm.nih.gov/pubmed/29770165 http://dx.doi.org/10.1155/2018/2389523

Ejemplares similares

Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy
por: Lauriola, Angela, et al.
Publicado: (2023)

Telomere Dysfunction Is Associated with Altered DNA Organization in Trichoplein/Tchp/Mitostatin (TpMs) Depleted Cells
por: Lauriola, Angela, et al.
Publicado: (2022)

Depletion of Trichoplein (TpMs) Causes Chromosome Mis-Segregation, DNA Damage and Chromosome Instability in Cancer Cells
por: Lauriola, Angela, et al.
Publicado: (2020)

ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age-Related Diseases
por: Davalli, Pierpaola, et al.
Publicado: (2016)

The 1,10-Phenanthroline Ligand Enhances the Antiproliferative Activity of DNA-Intercalating Thiourea-Pd(II) and -Pt(II) Complexes Against Cisplatin-Sensitive and -Resistant Human Ovarian Cancer Cell Lines
por: Marverti, Gaetano, et al.
Publicado: (2019)

Repurposing of Drugs Targeting YAP-TEAD Functions
por: Elisi, Gian Marco, et al.
Publicado: (2018)

Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth
por: Pacifico, Salvatore, et al.
Publicado: (2019)

Anticancer Activity of Green Tea Polyphenols in Prostate Gland
por: Davalli, Pierpaola, et al.
Publicado: (2012)

A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells
por: Marverti, Gaetano, et al.
Publicado: (2020)

Folic Acid–Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting
por: Marverti, Gaetano, et al.
Publicado: (2021)

Intracellular quantitative detection of human thymidylate synthase engagement with an unconventional inhibitor using tetracysteine-diarsenical-probe technology
por: Ponterini, Glauco, et al.
Publicado: (2016)

Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines
por: Losi, Lorena, et al.
Publicado: (2019)

Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library
por: Lauriola, Angela, et al.
Publicado: (2022)

Proteomic and Bioinformatic Studies for the Characterization of Response to Pemetrexed in Platinum Drug Resistant Ovarian Cancer
por: Severi, Leda, et al.
Publicado: (2018)

Structural Bases for the Synergistic Inhibition of Human Thymidylate Synthase and Ovarian Cancer Cell Growth by Drug Combinations
por: Pozzi, Cecilia, et al.
Publicado: (2021)

DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
por: Jurkovicova, Dana, et al.
Publicado: (2022)

Clusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF-κB-Dependent Mechanism
por: Bonacini, Martina, et al.
Publicado: (2019)

Targeting DNA damage response in cancer therapy
por: Hosoya, Noriko, et al.
Publicado: (2014)

Targeting the DNA damage response for cancer therapy
por: Curtin, Nicola J.
Publicado: (2023)

Targeting the DNA Damage Response for Cancer Therapy
por: Wang, Ruoxi, et al.
Publicado: (2023)

Hepatocellular Carcinoma in a non-Cirrhotic Liver of a HCV-Positive Woman with Sustained Viral Response
por: Nosotti, L., et al.
Publicado: (2011)

Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma
por: D’Arca, Domenico, et al.
Publicado: (2023)

Trichoplein binds PCM1 and controls endothelial cell function by regulating autophagy
por: Martello, Andrea, et al.
Publicado: (2020)

Ovarian Cancer: Opportunity for Targeted Therapy
por: Tagawa, Tomoko, et al.
Publicado: (2012)

Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage
por: Kelley, Mark R., et al.
Publicado: (2017)

Collateral Victim or Rescue Worker?—The Role of Histone Methyltransferases in DNA Damage Repair and Their Targeting for Therapeutic Opportunities in Cancer
por: He, Lishu, et al.
Publicado: (2021)

DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities
por: Abuetabh, Yasser, et al.
Publicado: (2022)

Targeting Integrins for Cancer Therapy - Disappointments and Opportunities
por: Bergonzini, Cecilia, et al.
Publicado: (2022)

Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth
por: Costantino, Luca, et al.
Publicado: (2022)

Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
por: Du, Ruijuan, et al.
Publicado: (2021)

Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic Opportunities
por: De Marco, Katia, et al.
Publicado: (2023)

Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1
por: Bukhari, Amirali B., et al.
Publicado: (2022)

Roles of DNA damage repair and precise targeted therapy in renal cancer (Review)
por: Lai, Yongchang, et al.
Publicado: (2022)

DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities
por: Ovejero-Sánchez, María, et al.
Publicado: (2023)

Oxidative Stress and DNA Damage Markers in Colorectal Cancer
por: Acevedo-León, Delia, et al.
Publicado: (2022)

Therapeutic Targeting of DNA Damage Response in Cancer
por: Choi, Wonyoung, et al.
Publicado: (2022)

Mitostatin Is Down-Regulated in Human Prostate Cancer and Suppresses the Invasive Phenotype of Prostate Cancer Cells
por: Fassan, Matteo, et al.
Publicado: (2011)

Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy
por: Galanopoulos, Michail, et al.
Publicado: (2021)

Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer
por: Oria, Victor Oginga, et al.
Publicado: (2023)

Current and novel therapeutic opportunities for systemic therapy in biliary cancer
por: Marin, José J. G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6dlsgbj0a72568naorr2c17btg